Cargando…

Corrigendum to “Angiogenesis in Pituitary Adenomas: Human Studies and New Mutant Mouse Models”

Detalles Bibliográficos
Autores principales:	Cristina, Carolina, Luque, Guillermina María, Demarchi, Gianina, Vicchi, Felicitas Lopez, Zubeldia-Brenner, Lautaro, Perez Millan, Maria Ines, Perrone, Sofia, Ornstein, Ana Maria, Lacau-Mengido, Isabel M., Berner, Silvia Inés, Becu-Villalobos, Damasia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383317/ https://www.ncbi.nlm.nih.gov/pubmed/32733555 http://dx.doi.org/10.1155/2020/8978014

Ejemplares similares

Angiogenesis in Pituitary Adenomas: Human Studies and New Mutant Mouse Models
por: Cristina, Carolina, et al.
Publicado: (2014)

Notch system is differentially expressed and activated in pituitary adenomas of distinct histotype, tumor cell lines and normal pituitaries
por: Perrone, Sofia, et al.
Publicado: (2017)

The Notch system during pubertal development of the bovine mammary gland
por: Bonadeo, Nadia, et al.
Publicado: (2019)

SUN-340 Prolactinoma Response to Bevacizumab Is Influenced by Tumor Progression Stage at the Beginning of Treatment
por: Valla, Sofia, et al.
Publicado: (2019)

Severe Hyperprolactinemia Promotes Brown Adipose Tissue Whitening and Aggravates High Fat Diet Induced Metabolic Imbalance
por: Lopez-Vicchi, Felicitas, et al.
Publicado: (2022)

Novel, Low Cost, Highly Effective, Handmade Steroid Pellets for Experimental Studies
por: Sahores, Ana, et al.
Publicado: (2013)

Corrigendum to “Identification of Differentially Expressed Genes in Pituitary Adenomas by Integrating Analysis of Microarray Data”
por: Zhao, Peng, et al.
Publicado: (2018)

Transcriptome Analysis Identifies an Attenuated Local Immune Response in Invasive Nonfunctioning Pituitary Adenomas
por: Kim, Yong Hwy, et al.
Publicado: (2020)

Editorial: Towards targeting prolactin signaling in human diseases: stimulate or inhibit?
por: Goffin, Vincent, et al.
Publicado: (2023)

SAT063 Dopaminergic Agonist Cabergoline Inhibits Autophagic Flux In Beta Pancreatic Cells
por: Francisco Mendez, Luis, et al.
Publicado: (2023)

Case Report: Progression of a Silent Corticotroph Tumor to an Aggressive Secreting Corticotroph Tumor, Treated by Temozolomide. Changes in the Clinic, the Pathology, and the β-Catenin and α-SMA Expression
por: Demarchi, Gianina, et al.
Publicado: (2022)

Non-functioning pituitary adenomas and pregnancy: one-center experience and review of the literature
por: Rosmino, Josefina, et al.
Publicado: (2020)

PTTG expression in different experimental and human prolactinomas in relation to dopaminergic control of lactotropes
por: Cristina, Carolina, et al.
Publicado: (2007)

Corrigendum to: Minimum requirements for the estimation of the measurement uncertainty: Recommendations of the joint Working group for uncertainty of measurement of the CSMBLM and CCMB
por: Ćelap, Ivana, et al.
Publicado: (2017)

Pituitary Adenoma Surgery Survey: Neurosurgical Centers and Pituitary Adenomas
por: Netuka, David, et al.
Publicado: (2022)

Corrigendum to: ACE inhibitor-induced small bowel angioedema, mimicking an acute abdomen
por: Parreira, Rafaela, et al.
Publicado: (2020)

Clinical Biology of the Pituitary Adenoma
por: Melmed, Shlomo, et al.
Publicado: (2022)

Endoscopic resection of supergiant pituitary adenoma
por: Penner, Federica, et al.
Publicado: (2021)

Pituitary Crooke Cell Adenoma: Two Cases of an Aggressive Pituitary Adenoma
por: Taiwo, Adeyinka, et al.
Publicado: (2023)

Identification of microRNAs associated with the aggressiveness of prolactin pituitary tumors using bioinformatic analysis
por: Wang, Zihao, et al.
Publicado: (2021)

Recent advances in understanding and managing pituitary adenomas
por: Markou, Maria, et al.
Publicado: (2023)

Cytology of Pituitary Adenomas
por: Doniach, I.
Publicado: (1972)

The Epigenomics of Pituitary Adenoma
por: Hauser, Blake M., et al.
Publicado: (2019)

The Genetics of Pituitary Adenomas
por: Tatsi, Christina, et al.
Publicado: (2019)

Corrigendum to “Glucose Oxidase Induces Cellular Senescence in Immortal Renal Cells through ILK by Downregulating Klotho Gene Expression”
por: Troyano-Suárez, Nuria, et al.
Publicado: (2016)

The Predictive Value of Pathologic Features in Pituitary Adenoma and Correlation with Pituitary Adenoma Recurrence
por: Kim, Jee Soon, et al.
Publicado: (2016)

Environmental enrichment rescues female-specific hyperactivity of the hypothalamic-pituitary-adrenal axis in a model of Huntington's disease
por: Du, X, et al.
Publicado: (2012)

From Pituitary Stem Cell Differentiation to Regenerative Medicine
por: Camilletti, Maria Andrea, et al.
Publicado: (2021)

MicroRNAs as Potential Biomarkers in Pituitary Adenomas
por: Donati, Simone, et al.
Publicado: (2021)

Monitoring of Body Condition in Dairy Cows to Assess Disease Risk at the Individual and Herd Level
por: Rearte, Ramiro, et al.
Publicado: (2023)

BIM-23A760 influences key functional endpoints in pituitary adenomas and normal pituitaries: molecular mechanisms underlying the differential response in adenomas
por: Ibáñez-Costa, Alejandro, et al.
Publicado: (2017)

Pituitary sex hormones enhance the pro-metastatic potential of human lung cancer cells by downregulating the intracellular expression of heme oxygenase-1
por: Abdelbaset-Ismail, Ahmed, et al.
Publicado: (2019)

Corrigendum to “Toxic Effects of Trazodone on Male Reproductive System via Disrupting Hypothalamic-Pituitary-Testicular Axis and Inducing Testicular Oxidative Stress”
por: Ilgın, Sinem, et al.
Publicado: (2018)

Double pituitary adenomas in a large surgical series
por: Zieliński, Grzegorz, et al.
Publicado: (2019)

Primary pituitary tubercular abscess mimicking as pituitary adenoma
por: Ranjan, Rakesh, et al.
Publicado: (2011)

Seeding of a Pituitary Adenoma or Atypical Pituitary Carcinoma?
por: Krueger, Evan M, et al.
Publicado: (2017)

Surgical treatment of aggressive pituitary adenomas and pituitary carcinomas
por: Buchfelder, Michael, et al.
Publicado: (2020)

Collision Tumor in the Pituitary, Concurrent Pituitary Adenoma, and Craniopharyngioma
por: Shareef, Zaid, et al.
Publicado: (2020)

The Progress of Immunotherapy in Refractory Pituitary Adenomas and Pituitary Carcinomas
por: Dai, Congxin, et al.
Publicado: (2020)

Pathology of the human pituitary adenomas
por: Osamura, Robert Y., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_es4r4g6bphd73hp1fhgh895mec